Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
01:41pNATUS MEDICAL : $64,343 Federal Contract Awarded to Natus Medical
AQ
01:27pMOLINA HEALTHCARE, INC. : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH
AC
01:25pSAGE THERAPEUTICS : Partners With Shionogi & Co. to Accelerate Development of SAGE-217 in Key Asian Markets, With Deal Value Potentially in Excess of $575 Million
AQ
01:24pRTI SURGICAL : Participant-Focused RTI Surgical Earns Prestigious Signature Award
AQ
01:02pVALEANT PHARMACEUTICALS INTL INC : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
AC
12:43pILLUMINA : $95,931 Federal Contract Awarded to Illumina
AQ
12:24pREVANCE THERAPEUTICS : RVNC) Reports Dosing of First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for Treatment of Cervical Dystonia
AQ
12:22pREVANCE THERAPEUTICS : Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia
AQ
12:21pBRISTOL MYERS SQUIBB : U.S. Food and Drug Administration (FDA) Accepts Application for Opdivo Plus Low-Dose Yervoy for Treatment of First-Line Non-Small Cell Lung Cancer in Patients with Tumor Mutational Burden 10 mut/Mb
AQ
11:33aCOLOPLAST A/S : Ostomy Bags (Coloplast) - Code
AQ
10:41aNANOBIOTIX : Announces Positive Phase II/III Topline Data In Soft Tissue Sarcoma With NBTXR3
AQ
10:41aCASI PHARMACEUTICALS : Drug Stock Soars on China Pharma Manufacturing Deal
AQ
10:23aVTV THERAPEUTICS : to Present a Poster at the American Diabetes Associations 78th Scientific Sessions
AQ
10:23aEYEGATE PHARMACEUTICALS : Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
AQ
10:22aPHARNEXT : to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 2018
AQ
10:22aDAIICHI SANKYO : The potential of antibody drug conjugates in the treatment of cancer
AQ
10:22aMATINAS BIOPHARMA : Announces Closing of $8.0 Million Public Offering
AQ
10:21aNOVO NORDISK A/S : Novos diabetes pill beats injections in head-to-head trials
AQ
10:21aVEEVA : New Clinical Studies Live on Veeva Vault EDC
AQ
10:21aCELLULAR BIOMEDICINE : Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
AQ
10:21aINDIVIOR : seeks injunction to block Dr. Reddys generic launch in US
AQ
10:21aNATERA : Develops Powerful Kidney Transplant Rejection Biomarker
AQ
10:20aRECIPHARM PUBL : acquires Sanofis inhalation assets
AQ
10:20aASTRAZENECA PHARMA INDIA : `s Imfinzi becomes India`s first available immunotherapy for lung cancer
AQ
04:51aACETO 72 HOUR DEADLINE ALERT : Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Aceto Corp.
BU
04:51aROCKWELL MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL : Kahn Swick & Foti, LLC Investigates the Officers and Directors of Rockwell Medical, Inc. - RMTI
BU
02:35aMOLINA HEALTHCARE : South Florida's 3 Obamacare providers file proposals to return in 2019
AQ
01:29aBAYER : Financial Risk Management Software Market valued at US$ 7.04 billion in 2017, is expected to reach US$ 13.99 billion in 2022, focusing on top key companies like Bayer AG, Pfizer Deutschland GmbH, Dents
AQ
01:22aBAYER : Dental Drugs Market valued at US$ 4.25 Mn in 2017 and is expected to reach US$ 5.43 Mn by 2022, focusing on top key comapies like Bayer AG
AQ
06/22GW PHARMACEUTICALS : Pending pot-based drug ruling raises fear Some fear changes to state laws as US weighs pot medicine
AQ
06/22RECRO PHARMA INC : SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
AC
06/22PROTHENA CORPORATION PLC : SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Prothena Corporation plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
AC
06/22AEVI GENOMIC MEDICINE, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
06/22DICERNA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22CORVUS PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22APRICUS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
06/22HERON THERAPEUTICS, INC. /DE/ : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22JOHNSON & JOHNSON : current report
PU
06/22CYTODYN INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/22JOHNSON & JOHNSON : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/22EAGLE PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22Pfenex Set to Join Russell 2000® Index
GL
06/22PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)
AQ
06/22JOUNCE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22ABBOTT LABORATORIES : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events (form 8-K)
AQ
06/22BROOKDALE SENIOR LIVING : Story of Teen’s Compassion Toward Brookdale Resident on Flight Ignites the Internet
PU
06/22ANALOGIC CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/22ALIMERA SCIENCES INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22IMMUNOMEDICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/22STEMLINE THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22BLUEPRINT MEDICINES CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22INVACARE CORPORATION : to Present at CJS Securities Summer Conference
BU
06/22AURINIA PHARMACEUTICALS : Announces Results of Annual General Meeting
BU
06/22MADRIGAL PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22PERNIX THERAPEUTICS HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/22ONCOBIOLOGICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/22NEOS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22REVANCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/22MATEON THERAPEUTICS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/22INTELLIA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
1  2  3  4  5  6  7  8  9  10Next
Advertisement